A Novel Framework for Comparing Combination Therapy Outcomes Using Mechanistic Graph Models
Background: Predicting the efficacy of combination therapies is a critical challenge in clinical decision-making, particularly for diseases requiring multi-drug regimens. Traditional evidence synthesis methods, such as component network meta-analysis (cNMA), often face parameter explosion and limited interpretability, especially when modeling interaction effects between components. Objective: This article introduces a general Efficacy Comparison Framework (ECF), a mechanistically grounded system for predicting combination therapy outcomes. ECF integrates biological pathway-based abstractions with expert knowledge, optimized with quasi-rules derived from clinical trial data to overcome the limitations of traditional methods. Methods: ECF employs a disease pathogenesis graph to encode domain knowledge, reducing the parameter space through mechanistic functions and sparse network structures. Optimization may be performed using a loss function inspired by the Thurstone-Mosteller model, focusing on pairwise regimen comparisons. A pilot study was conducted for acne vulgaris to evaluate ECF's ability in both tested and untested comparisons. Results: In the acne vulgaris case study, the ECF-based model achieved 76% accuracy in predicting both tested and untested regimen outcomes, demonstrating statistically comparable performance across clinical trial data and expert dermatologist consensus (p = 0.977). The agreement between ECF and expert predictions was within the range of inter-expert agreement. Discussion: ECF aligns with recent advancements in network science and synergy prediction, leveraging principles of complementary targeting and biological plausibility. Its use of disease pathogenesis graphs offers a more interpretable and scalable alternative to existing models reliant on chemical similarity or protein-protein interaction (PPI) topology.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Developing hybrid mechanistic and data-driven personalized prediction models for platelet dynamics
Hematotoxicity, drug-induced damage to the blood-forming system, is a frequent side effect of cytotoxic chemotherapy and poses a significant challenge in clinical practice due to its high inter-patient variability and li…
ConFER: A Neurally Constrained Computational Model of Context-Dependent Fear Extinction Recall and Relapse
Exposure therapy, a standard treatment for anxiety disorders, relies on fear extinction. However, extinction recall is often limited to the spatial and temporal context in which extinction is learned, leading to fear rel…
Identifying mechanisms driving the early response of triple negative breast cancer patients to neoadjuvant chemotherapy using a mechanistic model integrating in vitro and in vivo imaging data
Neoadjuvant chemotherapy (NAC) is a standard-of-care treatment for locally advanced triple negative breast cancer (TNBC) before surgery. The early assessment of TNBC response to NAC would enable an oncologist to adapt th…
SensitivityLearning to Route: Per-Sample Adaptive Routing for Multimodal Multitask Prediction
We propose a unified framework for adaptive routing in multitask, multimodal prediction settings where data heterogeneity and task interactions vary across samples. Motivated by applications in psychotherapy where struct…
Leveraging Large Language Models and Survival Analysis for Early Prediction of Chemotherapy Outcomes
Chemotherapy for cancer treatment is costly and accompanied by severe side effects, highlighting the critical need for early prediction of treatment outcomes to improve patient management and informed decision-making. Pr…